Foam technology revolutionizes gene therapy, boosting efficiency and safety

FHS
June 3, 2024
4:37 am

Liquid foam gene delivery significantly enhances transfection efficiency and safety, offering a cost-effective alternative to conventional methods.

Abivax Establishes an At-the-Market (ATM) Program on Nasdaq – Biotech Investments

EQS-News: ABIVAX / Key word(s): Miscellaneous Abivax Establishes an At-the-Market (ATM) Program on Nasdaq 19.11.2024 / 22:30 CET/CEST The issuer is solely responsible for the

November 20, 2024

Base-Edited CAR-T Product ‘Potent’ in Relapsed Childhood T-Cell ALL

The use of base editing to generate universal off-the-shelf chimeric antigen receptor (CAR) T cells in patients with relapsed T-cell acute lymphoblastic leukemia (ALL) should

June 15, 2023

CAR-T therapies and cancer risk: No easy answers for the FDA

Share this article While there is potential for correlation, there is not enough information to infer any causation, says Dr, Bruce Levine, professor at the

January 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.